Home - Products - Apoptosis - TNF - Dihydrodehydrodiconiferyl alcohol

Dihydrodehydrodiconiferyl alcohol

CAS No. 28199-69-1

Dihydrodehydrodiconiferyl alcohol( —— )

Catalog No. M29295 CAS No. 28199-69-1

Dihydrodehydrodiconiferyl alcohol is the methanolic extract of Liriodendron tulipifera.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 771 In Stock
5MG 653 In Stock
10MG 878 In Stock
25MG 1518 In Stock
50MG 2362 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dihydrodehydrodiconiferyl alcohol
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydrodehydrodiconiferyl alcohol is the methanolic extract of Liriodendron tulipifera.
  • Description
    Dihydrodehydrodiconiferyl alcohol is the methanolic extract of Liriodendron tulipifera.(In Vitro):Dihydrodehydrodiconiferyl alcohol isolated from L. tulipifera leaves and twigs exhibited selective antifibrotic activities toward the activated HSCs and suppressed TNF-α production in RAW264.7 macrophages. Dihydrodehydrodiconiferyl alcohol may be useful candidate for developing therapeutic agents for the prevention and treatment of hepatic fibrosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    TNF
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    28199-69-1
  • Formula Weight
    360.4
  • Molecular Formula
    C20H24O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(O)CC1=CC(OC)=C(O[C@H](C2=CC=C(O)C(OC)=C2)[C@H]3CO)C3=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Thalidomide

    Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.

  • MOSLOFLAVONE

    MOSLOFLAVONE showed promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC50 values of 0.71 μM and ?7.8 μM respectively.

  • Belimumab

    Belimumab(LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF).Belimumab is used in the study of fatigue and in the treatment of lupus nephritis and systemic lupus erythematosus.